Velneperit

DB12889InvestigationalSmall molecule

Velneperit has been used in trials studying the treatment of Obesity.

Mechanism: Pharmacologically active on Neuropeptide Y receptor type 5
Curator reviewed
Formula / weight: C₁₇H₂₄F₃N₃O₃S · 407.45 g/mol (avg)
Code names: S-2367

Resolves to

Compound

Structure

InChIKeyWGEWUYACXPEFPO-AULYBMBSSA-NSMILESCC(C)(C)S(=O)(=O)N[C@H]1CC[C@@H](CC1)C(=O)NC1=NC=C(C=C1)C(F)(F)F

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Velneperit, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.